Vijaya Diagnostic Centre and Medinova Diagnostic Services announce merger to enhance diagnostic services

Vijaya Diagnostic Centre and Medinova Diagnostic Services announce merger to enhance diagnostic services

In a significant move in the healthcare industry, Vijaya Diagnostic Centre Limited (VDCL) and Medinova Diagnostic Services Limited (MDSL) have announced their amalgamation. This merger, approved by the Board of Directors of both companies, aims to consolidate their operations and create synergies, enhancing value for all stakeholders involved. The scheme of amalgamation will see MDSL […]

Merck to acquire EyeBio in $3bn deal to expand ophthalmology pipeline

Merck to acquire EyeBio in $3bn deal to expand ophthalmology pipeline

Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, has announced a definitive agreement to acquire EyeBio Limited, a prominent ophthalmology-focused biotechnology company, in a deal worth up to $3 billion. This acquisition includes an upfront payment of $1.3 billion in cash, with additional developmental, regulatory, and commercial milestone payments […]

Integrated Oncology Network acquires Urology Partners to enhance healthcare services in Cleveland

Integrated Oncology Network acquires Urology Partners to enhance healthcare services in Cleveland

Integrated Oncology Network, LLC (ION), backed by Silver Oak Services Partners, LLC, has announced its acquisition of Urology Partners, LLC, a renowned private practice urology group. This acquisition marks a significant enhancement in healthcare services in the Cleveland area by combining the expertise of two leading urology providers, Southwest Urology and Urology Partners, LLC. Details […]

Johnson & Johnson announces $13.1bn acquisition of Shockwave Medical to strengthen medtech division

Johnson & Johnson announces $13.1bn acquisition of Shockwave Medical to strengthen medtech division

In a monumental move within the medical technology sector, Johnson & Johnson (NYSE: JNJ) has announced its acquisition of Shockwave Medical, Inc. (Nasdaq: SWAV) for a staggering $335.00 per share in cash. This acquisition, translating to an enterprise value of approximately $13.1 billion, marks a significant expansion of Johnson & Johnson’s MedTech division, specifically within […]